Drug Type AAV based gene therapy |
Synonyms AAV-ZF-R-PRNP (Sangamo Therapeutics) |
Target |
Action inhibitors |
Mechanism PRNP inhibitors(prion protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Prion Diseases | Preclinical | United States | 17 May 2023 |





